Personalised medicine patents disputed at US Supreme Court
A patent for a diagnostic test is currently under consideration by the US Supreme Court. The eventual decision may have profound implications for the burgeoning 'personalised medicine' industry which often relies on DNA tests to guide physicians in choosing tailored therapies for patients...
Comment
Progress Educational Trust Conference: Growing Concern?
by Mila Roode
The consequences of assisted reproductive technology (ART) are a matter of great concern, whether this is the development of the embryo, the perinatal health of the mother, or the ongoing health of the child....
Private data - for the public good?
by Sharmila Nebhrajani
Our medical records include some of the most personal and sensitive information about us. So it's understandable that two items in David Cameron's life sciences strategy caused considerable stir...
Progress Educational Trust Conference: Should Assisted Conception Always Be Evidence-Based?
by Dr Rebecca Hill
In what is now synonymous with Progress Educational Trust (PET)'s ethos, the final session of the annual conference, 'The Best Possible Start in Life: The Robust and Responsive Embryo', was a free-form debate. Following on from the previous sessions where a wealth of eminent researchers gave informative and often provocative talks, Guardian columnist Zoe Williams had the task of chairing what proved to be an entertaining debate...